Patent Assignment
Reel/Frame 029940/0296
Merger
Recorded: 2013-03-08
Pages: 98
Assignor
ORGANON BIOSCIENCES NEDERLAND B.V.
Executed: 2013-01-02
Assignee
MERCK SHARP & DOHME B.V.
WAARDERWEG 39, BN HAARLEM, 2031, NETHERLANDS
Covered Properties
(185)
Process for the preparation of 7alpha-methylsteroids
Application:
10/502,259 →
Publication:
US US20050090476A1
X-Ray Visible Drug Delivery Device
Drug Delivery System Based on Polyethylene Vinylacetate Copolymers
Pharmaceutical composition comprising a salt of mirtazapine
Application:
11/547,152 →
Publication:
US US20070111993A1
Applicator for Inserting an Implant
Applicator for Inserting an Implant
Method of Treatment of Hormone Depletion Induced Vasomotor Symptoms
Application:
11/917,456 →
Publication:
US US20090306046A1
Regimens for Controlled Drug Delivery Devices for Contraception
Application:
11/917,485 →
Publication:
US US20080206310A1
Regimens for Oral Monophasic Contraceptives
Application:
11/917,492 →
Publication:
US US20080207571A1
Accurate Method to Assess Disease Severity in Clinical Trials Concerning Psychopathology
Application:
12/056,741 →
Publication:
US US20090024003A1
Non-Steroidal Compounds Useful as Glucocorticoid Receptor Modulators
Method for the Preparation of an Enantiomer of a Tetracyclic Benzazepine
Application:
12/098,662 →
Publication:
US US20080255348A1
Kit for and Method of Assembling an Applicator for Inserting an Implant
Drug Delivery System
Stereoselective Synthesis of (S)-1-Methyl-3-Phenylpiperazine
Application:
12/304,557 →
Publication:
US US20100036126A1
Purines as Pkc-Theta Inhibitors
Application:
12/445,862 →
Publication:
US US20110046131A1
Oral Contraceptive Spray
Application:
12/518,732 →
Publication:
US US20100105641A1
Mineralocorticoid Receptor Antagonists
Application:
12/593,746 →
Publication:
US US20100120736A1
Helically-Shaped Drug Delivery System
Application:
12/594,169 →
Publication:
US US20100136090A1
Tsh Receptor Antagonizing Tetrahydroquinoline Compounds
Tricyclic Heterocyclic Derivatives
Application:
12/678,184 →
Publication:
US US20100210680A1
Intrauterine System
Apparatus and Method for Preserving Mucosa
Application:
12/841,864 →
Publication:
US US20110020177A1
Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines
Dihydro)Pyrrolo[2,1-A]Isoquinolines
Novel Androgens
Application:
12/887,607 →
Publication:
US US20110009428A1
PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
Application:
12/936,604 →
Publication:
US US20110218189A1
Indane Derivatives as Ampa Receptor Modulators
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Application:
13/049,139 →
Publication:
US US20110166363A1
1-(4-Ureidobenzoyl)Piperazine Derivatives
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Antibodies Against a Proliferating Inducing Ligand (April) and Methods of Use Thereof
Conjugates of a Polypeptide and an Oligosaccharide
Application:
13/227,910 →
Publication:
US US20120039843A1
Tricyclic Heterocyclic Derivatives
Isoxazole-5-Carboxamide Derivatives
Application:
13/256,553 →
Publication:
US US20120071481A1
Isoxazole-5-Carboxamide Derivatives
Application:
13/256,561 →
Publication:
US US20120095002A1
Process to Form an Orally Disintegrating Tablet for Human Use
2-(1,2-Benzisoxazol-3-Yl)Benzylamine Derivatives
Antithrombotic Dual Inhibitors Comprising a Biotin Residue
1H-[1,2,3]Triazolo[4,5-C]Pyridine-4-Carbonitrile Derivatives
S-Mirtazapine for the Treatment of Hot Flush
Application:
13/570,481 →
Publication:
US US20120302552A1
Intrauterine Deposit
Application:
13/622,031 →
Publication:
US US20130014763A1
Timer
Patent:
460,004 →
Application:
29/138,849 →
Applicator for Inserting an Implant
Patent:
551,759 →
Application:
29/242,104 →
Timer
Patent:
472,162 →
Application:
29/160,362 →
Slide Case Tablet Dispenser
Patent:
647,295 →
Application:
29/342,894 →
Slide Case Tablet Dispenser
Patent:
645,658 →
Application:
29/342,896 →
Slide Case Tablet Dispenser
Patent:
645,244 →
Application:
29/342,900 →
Low Steroid Dose Dry Pharmaceutical Preparation
Patent:
5,382,434 →
Application:
08/216,236 →
Spike Retainer System
Patent:
5,472,434 →
Application:
08/061,031 →
Pharmaceutical Granulate
Patent:
5,527,543 →
Application:
08/366,348 →
Method for Preparing 213 Bi for Therapeutic Use
Patent:
5,641,471 →
Application:
08/527,296 →
Lyospheres Comprising Gonadotropin
Patent:
5,656,597 →
Application:
08/454,333 →
Antiglucocorticoid Steroids for the Treatment of Anxiety Disorders
Patent:
5,741,787 →
Application:
08/581,631 →
Sublingual or Buccal Pharmaceutical Composition
Patent:
5,763,476 →
Application:
08/693,064 →
Drug Delivery System for Two or More Active Substances
Patent:
5,989,581 →
Application:
09/056,700 →
Tetrahydroimidazo[2,1-A]Isoquinoline Derivatives
Patent:
5,994,366 →
Application:
09/104,563 →
Method of Preparing a Monoclonal Antibody
Patent:
6,020,170 →
Application:
08/985,898 →
Process for the Microbial Conversion of Phytosterols to Androstenedione and Androstadienedione
Patent:
6,071,714 →
Application:
09/048,432 →
Steroid Compounds Having Contraceptive and Anti-Osteoporsis Activity
Patent:
6,077,873 →
Application:
09/026,348 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent:
6,080,773 →
Application:
08/950,359 →
Therapeutic Combinations of Mirtazapine and Antipsychotic Agents, for the Treatment or Prophylaxis of Psychotic Disorders
Patent:
6,150,353 →
Application:
09/380,723 →
Isolated Human Bmp-4 Promoter Region
Patent:
6,159,696 →
Application:
09/308,406 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,194,409 →
Application:
09/403,327 →
Process for the Production of Heparin
Patent:
6,232,093 →
Application:
09/462,223 →
Derivatives of azetidine and pyrrolidine
Patent:
6,281,243 →
Application:
09/622,705 →
Benzylamine Derivatives Which Are Useful in Treating Psychiatric Disorders
Patent:
6,313,139 →
Application:
09/359,284 →
Steroid compounds having contraceptive and anti-osteoporosis activity
Patent:
6,313,180 →
Application:
09/538,783 →
Drug of Improving Optic Nerve Head Circulation Disorder
Patent:
6,387,910 →
Application:
09/601,231 →
Method of Preparing a Monoclonal Antibody, a Pharmaceutical Composition and a Diagnastic Reagent
Patent:
6,392,020 →
Application:
09/405,745 →
Compounds of Azetidine and Pyrroline
Aminomethylcarboxylic Acid Derivatives
Patent:
6,410,592 →
Application:
09/744,520 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,432,955 →
Application:
09/679,232 →
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Patent:
6,444,672 →
Application:
09/550,954 →
Antithrombotic Compounds
Patent:
6,486,129 →
Application:
09/719,841 →
Solid Phase Supports
Patent:
6,486,354 →
Application:
09/485,613 →
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Patent:
6,569,863 →
Application:
09/937,416 →
Spiro(2H-1-Benzopyran-2,4-Piperidine)Derivates as Glycine Transport Inhibitors
Patent:
6,645,973 →
Application:
10/130,557 →
Gonadotropin Releasing Hormone Antagonist
Patent:
6,653,286 →
Application:
09/446,324 →
Folliculogenesis
Patent:
6,660,717 →
Application:
09/856,995 →
6-Mercapto-Cyclodextrin Derivatives:Reversal Agents for Drug-Induced Neuromuscular Block
Patent:
6,670,340 →
Application:
10/148,307 →
Estrogen Receptor Beta
Patent:
6,680,368 →
Application:
09/608,088 →
Method for identifying Ligand of estrogen receptor beta
Patent:
6,713,270 →
Application:
09/711,288 →
10-Aryl-11H-Benzo[B]Fluorene Derivatives and Analogs for Medicinal Use
Heterocyclic Derivatives and Their Use as Antithrombotic Agents
Bicyclic Heteroaromatic Compounds Useful as Lh Agonists
Process for the Preparation of Peptides
Antithrombotic Compound
14-Beta,17-Alpha-Hydroxymethylandrostane Derivatives as Androgens
Patent:
6,881,728 →
Application:
09/890,845 →
Use of Mirtazapine for the Treatment of Sleep Disorders
6-Mercapto-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
14 Beta, 16, 17-Methylene Steroids as Novel Androgens
2-Alkylated-Cyclodextrin Derivatives: Reversal Agents for Drug-Induced Neuromuscular Block
Dna Encoding
Patent:
7,060,490 →
Application:
08/826,361 →
17ALPHA-Hydroxy-14BETA-Steroids with Hormonal Effect
Vinyl Sulphone Modified Polymer
Chroman Derivatives as Estrogenic Compounds
Bicyclic Heteroaromatic Compounds
Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block
Patent:
7,265,099 →
Application:
10/049,393 →
1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives
Tetrahydrobenzfluorene Derivatives
Benzoxazepines Derivatives and Their Use as Ampa Receptor Stimulators
THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
Etonogestrel Esters
4-Phenyl-6-Substituted-Pyrimidine-2-Carbonitrile Derivatives
Full Length Human HCN1IH Channel Subunit and Variants
Substituted 10-Aryl-11H-Benzo[B]Fluourenes and 7-Aryl-5, 6-Dihydro-Benzo[a]Anthracenes for Selective Effects on Estrogen Receptors
(Pyrido/Thieno) - [F] - Oxazepine-5-One Derivatives
Electronic Alarm Timer for Use with a Medical Regimen
Patent:
7,369,463 →
Application:
10/203,196 →
Glycine-Substituted Thieno[2,3-D]Pyrimidines with Combined Lh and Fsh Agonistic Activity
Process for Rapid Solution Synthesis of Peptides
C-14 Oxidation of Morphine Derivatives
2-(Benzimidazol-1-Yl)-Acetamide Bisaryl Derivatives
Benzoxapzepine Derivatives and Their Use as Ampa Receptor Stimulators
Spiro(2H-1BENZOPYRAN-2,4'-Piperidine) Derivates as Glycine Transport Inhibitors
Chroman Derivatives as Estrogenic Compounds
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
8-Azabicyclo[3.2.1]Octane Derivatives
Bicyclic Heteroaromatic Compounds
Isoquinoline Derivatives
Indole Derivatives
Tetrahydrobenzfluorene Derivatives
Tetrahydorquinoline Derivatives and Their Use as Fsh Receptor Modulators
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Progesterone Receptor Modulators
(Indol-3-Yl) Heterocycle Derivatives as Agonists of the Cannabinoid CB1 Receptor
Non-Steroidal Progesterone Receptor Modulators
Crystal Form of Asenapine Maleate
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Indole Derivatives
Tricyclic 1-[(Indol-3-Yl)Carbonyl]Piperazine Derivatives as Cannabinoid CB1 Receptor Agonists
Indoles Useful in the Treatment of Androgen-Receptor Related Diseases
2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists
Novel Androgens
Quinazolinone and Isoquinolinone Acetamide Derivatives
Heterocyclic Derivatives
15 Beta-Substituted Steroids Having Selective Estrogenic Activity
1-Arylsulfonyl-3-Substituted Indole and Indoline Derivatives Useful in the Treatment of Central Nervous System Disorders
Chroman Derivatives as Estrogenic Compounds
Tetrahydroquinoline Derivatives
9-Azabicyclo[3.3.1]Nonane Derivatives
16,17-Carbocyclic Condensed Steroid Compounds Having Selective Estrogenic Activity
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]Oxepino[4,5-C]Pyrrole
6-Substituted Isoquinoline Derivatives
2-(1-Oxo-1H-Isoquinolin-2-Yl)Acetamide Derivatives
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
Intermediate Compounds for the Preparation of Trans-5-Chloro-2-Methyl-2,3,3A,12B-Tetrahydro-1H-Dibenz[2,3:6,7]-Oxepino[4,5-C]Pyrrole
Compounds with Medicinal Effects Due to Interaction with the Glucocorticoid Receptor
1-(Biphenyl-4-Ylmethyl)Imidazolidine-2,4-Dione
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
New Progesterone Receptor Modulators
Dihydropyridine Derivatives
Method for the Preparation of an Enantiomerically Pure Benzazepine
4-Phenyl-5-Oxo-1,4,5,6,7,8- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
4-Phenyl-5-Oxo-1,4,5,6,7,8-Hexahydroquinoline Derivatives for the Treatment of Infertility
Crystal Form of Asenapine Maleate
6-Phenyl-1H-Imidazo[4,5-C]Pyridine-4-Carbonitrile Derivatives
(Pyrido/Thieno)-[F]-Oxazepine-5-One Derivatives
4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
Method for the Preparation of Enantiomerically Pure Mirtazapine
Tetrahydroquinoline Derivatives
New Progesterone Receptor Modulators
Tetrahydronaphthalen-2-Ol Derivatives
(Dihydro)Imidazoiso[5,1-A]Quinolines
Dihydrobenzoindazoles
Conjugates of a Polypeptide and a Pentasaccharide
Selective Enzymatic Amidation of C-Terminal Esters or Acids of Peptides
Non-Steroidal Androgens Compounds
Substituted Thieno[2,3-D]Pyrimidines as Ampa Modulators
Non Steroidal Glucocorticoid Receptor Modulators
1-(4-(Pyridin-2-Yl)Benzyl)Imidazolidine-2,4-Dione Derivatives
Antithrombotic Dual Inhibitors Comprising a Biotin Residue
Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label
(Pyrrolidin-2-Yl)Phenyl Derivatives
5- Phenyl-Isoxazole-3-Carboxamide Derivatives as TRPV1 Modulators
Process for the Preparation of Asenapine and Intermediate Products Used in Said Process
Tetrahydroquinoline Derivatives
Process for the Preparation of Estrone and/or Estradiol-Derivates
Intrauterine Deposit
Aminoisoquinoline Thrombin Inhibitor with Improved Bioavailability
N-Benzyl,N'-Arylcarbonylpiperazine Derivatives
Drug Delivery System
Antibodies to Human Programmed Death Receptor Pd-1
Hexafluoroisopropanol Derivatives
Substituted 16,17-Annellated Steriod Compounds for Use in Womens Healthcare
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2010
From: GROEN, MARINUS BERNARD; PETERS, BERNARDUS WYAND MACHIJS MARIE; PLATE, RALF
To: N.V. ORGANON
Reel/Frame 023862/0794 →
Assignment of Assignor's Interest
Jan 28, 2010
From: VAN VLIET, MICHIEL CHRISTIAN ALEXIANDER; KEMPERMAN, GERARDUS JOHANNES; GOEDHEIJT, MARCEL SCHREUDER
To: N.V. ORGANON
Reel/Frame 023862/0870 →
Assignment of Assignor's Interest
Jan 28, 2010
From: SCHOEMAKER, J.H.
To: N.V. ORGANON
Reel/Frame 023862/0909 →
Merger
Dec 1, 2011
From: N.V. ORGANON
To: MSD OSS B.V.
Reel/Frame 027307/0482 →
Merger
Mar 7, 2013
From: MSD OSS B.V.
To: ORGANON BIOSCIENCES NEDERLAND B.V.
Reel/Frame 029939/0001 →